Reuters logo
BRIEF-Cymabay Therapeutics to initiate its next phase 2 study of MBX-8025
October 5, 2016 / 12:52 PM / a year ago

BRIEF-Cymabay Therapeutics to initiate its next phase 2 study of MBX-8025

Oct 5 (Reuters) - Cymabay Therapeutics :

* Initiates its next phase 2 study of MBX-8025 in primary biliary cholangitis

* Initiation of phase 2 study is expected by year end 2016. Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below